大都会人寿

MetLife's 15-min chart signals MACD Death Cross and narrowing Bollinger Bands.

MetLife's 15-Minute Chart Sees RSI Oversold, KDJ Golden Cross

MetLife's 15min chart: MACD Death Cross and KDJ Death Cross triggered.

MetLife: Keefe, Bruyette & Woods Reinstates Outperform Rating, PT at $87.

MetLife's 15min chart triggers MACD Death Cross, bearish Marubozu pattern observed.

Catalyst<ul> <li>Most analysts rate MET Buy or Strong Buy, showing broad institutional optimism.</li> <li>The company maintains strong cash reserves relative to market value.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a volatile state and the direction is not clear enough.</li> <li>Bearish signals are obviously dominant (2 bearish vs 0 bullish).</li> <li>Fund flow trends show negative overall outflow with large and extra-large orders contributing.</li></ul>

Key Factors

MetLife, Inc. MET shares have declined 11.7% year to date, underperforming the broader insurance industry's 10.4% decline.

MET News